Find your path to Stephan
293 people in our graph share verified history with Stephan — schools, employers, funds. One of them is your warm intro.
Steph ScottunlockedStephan: together at Amgen (2008–2009)
×10Stephan: together at Amgen
Stephan: together at Ludwig-Maximilians-Universität München
About
Stephan Braun serves as fractional Chief Medical Officer at Peptomyc and provides strategic consulting for oncology drug development, with experience spanning strategic portfolio development, early drug development, clinical-regulatory strategy, and biomarker development. He is board-certified in Obstetrics & Gynecology and qualified in Gyneco-Oncology and Senology. Braun is also a MedTech entrepreneur, company co-founder, and patent holder.
CMO at Hephaistos-Pharma
Intro paths
→
In turn, Stephan can intro founders to Hephaistos-Pharma's investors below.
Hephaistos-Pharma's investors · 4
Co-founders at Hephaistos-Pharma
MC
Martine CaroffScientific Founder
Experience
- PeptomycChief Medical Officer (fractional)current2026 — presentBarcelona, Catalonia, Spain
- HEPHAISTOS-PharmaChief Medical Officer (fractional)current2026 — presentOrsay, Île-de-France, Frankreich
- STRONCON GmbHFounder & CEOcurrent2026 — presentZurich, Switzerland
- ImCheck TherapeuticsChief Medical Officer2024 — 2026Marseille, Provence-Alpes-Côte d'Azur, France
- Safe Implant TechnologyCo-founder, CMO2018 — 2026Copenhagen Metropolitan Area
- cureteq AGChief Medical Officer2022 — 2024Zug, Switzerland
- Oncoteq AGMember Board Of Directors2022 — 2023Zug, Switzerland
- Basilea PharmaceuticaHead of Development2018 — 2022Basel, Basel, Switzerland
- Ipsen Pharma GmbHSenior Vice President; Head of Development, Oncology TA, R&D2016 — 2018Greater Paris Metropolitan Region
- PAREXELGlobal TA Lead, Oncology & Hematology2015 — 2016Berlin
- Symphogen A/SVice-President, Clinical R&D2013 — 2015Ballerup
- AmgenMedical Director2008 — 2013Zug
- UniversitätsklinikenMünchen, Innsbruck1994 — 2008
Skills & more
Strategie2ManagementLeadershipPatientensicherheit1Projektmanagement1Consulting2Führungskräfteberatung1Start-up-Unternehmen1Business Development2Ärztegruppen1Medizinische Ausbildung1Medizin
+12 more
GeschäftsführerClinical DevelopmentMedical AffairsMedical StrategyMedical StatisticsLine ManagementBusiness StrategyChange ManagementOncologyGynecologic OncologyTranslational ResearchKlinische EntwicklungLanguages Deutsch · Englisch · Französisch
From Stephan's professional profile.
Frequently asked questions
- Who is Stephan Braun?
- Stephan Braun serves as fractional Chief Medical Officer at Peptomyc and provides strategic consulting for oncology drug development, with experience spanning strategic portfolio development, early drug development, clinical-regulatory strategy, and biomarker development. He is board-certified in Obstetrics & Gynecology and qualified in Gyneco-Oncology and Senology. Braun is also a MedTech entrepreneur, company co-founder, and patent holder.
- Where does Stephan Braun work?
- Stephan Braun is CMO at Hephaistos-Pharma.
- Where did Stephan Braun go to school?
- Stephan Braun studied at University of St.Gallen (Swiss Board School - Corporate Governance, Corporate Governance); Ludwig-Maximilians-Universität München (Doctor of Medicine (MD), Medicine).
Same school
Also attended University of St.Gallen419
Melissa DonohoeVice President at Notion CapitalMarjolaine CatilPrincipal at Newfund CapitalGülce KoçInvestment Manager at IdacapitalDominik MatykaInvestor at Cavalry VenturesChristian NagelInvestor at Earlybird Venture CapitalKarol CieslukAssociate at TCV
+ 413 more
Also attended Ludwig-Maximilians-Universität München247
Julia SchrameierAssociate at Manta Ray VenturesCeline XiaoInvestor at DN CapitalFriedrich von WulffenPrincipal at Burda Principal InvestmentsElçinTalent Team at Hummingbird VenturesLaura WeigertSenior Associate at Marlin Equity PartnersToby TriebelPartner at FinTech Collective
+ 241 more
